Results 71 to 80 of about 85,247 (140)

Targeting the Rift Valley Fever Virus Polymerase: Resistance Mechanisms and Structural Insights. [PDF]

ACS Infect Dis
Král' M, Das A, Kotačka T, Blahošová A, Liščáková V, Hodek J, Konvalinka J, Demo G, Kožíšek M.   +8 more
europepmc   +1 more source

Efficient <i>in vitro</i> assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains. [PDF]

Antimicrob Agents Chemother
Woodall M, Ellis S, Zhang S, Kembou-Ringert J, Kite K-A, Buggiotti L, Jacobs AI, Agyeman AA, Masonou T, Palor M, McHugh TD, Breuer J, Standing JF, Smith CM.   +13 more
europepmc   +1 more source

De novo recovery of Ghana virus, an African bat Henipavirus, reveals differential tropism and attenuated pathogenicity compared to Nipah virus. [PDF]

Cell Rep
Haas GD, Escaffre O, Reis RA, Juelich TL, Smith JK, Zhang L, Kalveram BK, Guzmán-Solís AA, Vyshenska D, Klain W, Greninger AL, Freiberg AN, Lee B.   +12 more
europepmc   +1 more source

Application of versatile reverse genetics system for feline coronavirus. [PDF]

Microbiol Spectr
Kida I, Tamura T, Kuroda Y, Fukuhara T, Maeda K, Matsuno K.   +5 more
europepmc   +1 more source

Pharmacokinetics of Molnupiravir in Cats with Naturally Occurring Feline Infectious Peritonitis. [PDF]

Pathogens
Černá P, Wittenburg L, Hawley J, Willis M, Siegenthaler B, Lappin MR.   +5 more
europepmc   +1 more source

Response of tactile receptors to intermittent stimulation

Journal of Physiology, 1931
M. Cattell, H. Hoagland
semanticscholar   +1 more source

ToxPoint: The case for Equilibrative Nucleoside Transporters in current regulatory guidance. [PDF]

Toxicol Sci
Martinez-Guerrero L, Tang X, Ekins S, Wright SH, Cherrington NJ.   +4 more
europepmc   +1 more source

Divergent sustainability profiles of molnupiravir synthesis routes are governed by solvent use and process design. [PDF]

Proc Natl Acad Sci U S A
Chen Z, Lian JZ, Huang H, Zhu H, Kanye LT, Chen M, Zhang Z, Liu B, Zhang J, Ahmed A, Barbarossa V, Cucurachi S, Dong B.   +12 more
europepmc   +1 more source

SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2. [PDF]

Antiviral Res
Pandey K, Acharya A, Pal D, Jain P, Singh K, Durden DL, Kutateladze TG, Deshpande AJ, Byrareddy SN.   +8 more
europepmc   +1 more source

The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity. [PDF]

J Virol
Grimes SL, Heaton BE, Anderson ML, Burke K, Stevens L, Lu X, Heaton NS, Denison MR, Anderson-Daniels J.   +8 more
europepmc   +1 more source